Protagenic Therapeutics Inc. (PTIX)

[lukin4winners]

ATRNQ change to ATRN around mid May check the 10Q on this board here's an excerpt of 5% beneficial owners.

The information presented in this table is based on 400,000,000 shares of our common stock outstanding on June 25, 2014. Unless otherwise indicated, the address of each of the named executive officers and directors and 5% or more stockholders named below is c/o Atrinsic, Inc., 1 Grand Central Place, Suite 2319, New York, NY 10165.



Name of Beneficial Owner
Number of Shares

Beneficially Owned
Percent of
Class

Edward Gildea, Chief Executive Officer and Director 100,000,000 (1) 20.00 %
Jonathan Schechter, Director 50,000,000 (2) 11.11 %
All directors and executive officers as a group (2 persons) 150,000,000 (3) 27.27 %
5% Stockholders:
Sebastian Giordano 125,000,000 (4) 23.81 %
Hudson Bay Capital Management LP. (5)(7) 44,395,067 (7) 9.99 %
Iroquois Capital Management LLC (6)(7) 44,395,067 (7) 9.99 %
469 Holdings LLC (8) 22,693,437 5.67 %
Brilliant Digital Entertainment Altent, Inc.(9) 62,519,414 15.63 %
Google, Inc.(10) 100,047,815 25.01 %
MediaNet Digital, Inc. (11) 20,071,696 5.02 %

____________________

(1) Consists of 100,000,000 shares of common stock issuable under currently outstanding options.

(2) Consists of 50,000,000 shares of common stock issuable under currently outstanding options.

(3) Consists of an aggregate of 150,000,000 shares of common stock issuable under currently outstanding options.

(4) Consists of 125,000,000 shares of common stock issuable under currently outstanding options. Mr. Giordano resigned as chief executive officer effective March 1, 2014.